MDCO News and Press, The Medicines Company From 07/17/19

The Medicines Company (NASDAQ: MDCO) will host a conference call and audio webcast on Wednesday, July 24, 2019 at 8:30 a.m. EDT to discuss its second quarter 2019 financial results and operational developments. The conference call may be accessed by telephone as follows: A live audio ...

John McCamant , editor of The Medical Technology Stock Letter , chose The Medicines Co. ( MDCO ) as his top speculative idea for 2019. The stock has since risen 90%. Here's his latest update on this biotechnology play. After the positive ORION-3 update at the National Lipid...

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

The Medicines Company (NASDAQ: MDCO ) has priced its public offering of 4,545,455 common shares at $33.00/share. for gross proceeds of ~$150M. More news on: The Medicines Company, Healthcare stocks news, Read more ...

The Medicines Company (NASDAQ:MDCO) (the “Company”) today announced the pricing of a public offering of 4,545,455 shares of its common stock at a public offering price of $33.00 per share. Gross proceeds of the offering are expected to be approximately $150 million, before under...

The Medicines (NASDAQ: MDCO ) has launched a public offering of $150M of common stock. More news on: The Medicines Company, Healthcare stocks news, Read more ...

The Medicines Company (NASDAQ:MDCO) (the “Company”) today announced the launch of a public offering of $150.0 million of shares of its common stock. In addition, the underwriters will be granted a 30-day option to purchase from the Company up to an additional $22.5 million of sh...

Biotech Pulse Biotech shares are up this year, as represented by the Nasdaq Biotechnology Index ( IBB ), which is the industry benchmark, and the S&P Select Biotechnology Index ( XBI ), after a sharp decline in 2018. This is a welcome respite for biotech investors. However, it has not ...

Often those that criticise others reveal what he himself lacks." - Shannon L. Alder For the sixth straight week, the market posted a weekly decline in a holiday-shortened trading week last week. June started off on a down note as the market fell again largely as a result of the sell-off ...

InsiderInsights' Daily Round-Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signi...